Westpac Banking Corp Bluebird Bio, Inc. Transaction History

Westpac Banking Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$59.1 - $93.26 $2 Million - $3.16 Million	-33,911 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$88.86 - $117.49 $1.44 Million - $1.9 Million	-16,186 Reduced 32.31%	33,911 $0
Q2 2018 Jul 18, 2018	BUY	$99.64 - $127.59 $1.5 Million - $1.92 Million	15,013 Added 42.79%	50,097 $0
Q1 2018 May 01, 2018	BUY	$105.8 - $150.94 $157,853 - $225,202	1,492 Added 4.44%	35,084 $0
Q4 2017 Jan 18, 2018	BUY	$81.25 - $130.7 $471,250 - $758,059	5,800 Added 20.87%	33,592 $0

Q3 2017 Oct 30, 2017	BUY	$57.74 - $91.42 $1.6 Million - $2.54 Million	27,792	27,792 $0

20.2M

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $383M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Westpac Banking Corp with notifications on news.